Judging the Archon Genomics X PRIZE for whole human genome sequencing
Since the AGXP was launched in 2006, there have been important advances in DNA sequencing technologies both in terms of speed and reduction in costs. However, no current human genome sequence is fully complete, fully accurate or certain to contain all rearrangements or information of chromosome phasing (haplotype). Highly repetitive and other regions remain difficult to sequence but are likely critical in defining heritable features. Hence the ideals of the Prize remain as critical for the future of human genetics and genetic medicine as ever.